carbamylhydrazine has been researched along with vanadates in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abella, A; Carpéné, C; Marti, L; Palacín, M; Testar, X; Zorzano, A | 1 |
Boucher, J; Bour, S; Carpéné, C; Ordener, C; Parini, A; Prévot, D; Valet, P; Visentin, V | 1 |
2 other study(ies) available for carbamylhydrazine and vanadates
Article | Year |
---|---|
Combined treatment with benzylamine and low dosages of vanadate enhances glucose tolerance and reduces hyperglycemia in streptozotocin-induced diabetic rats.
Topics: Adipocytes; Animals; Benzylamines; Biological Transport; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Glucose; Glucose Intolerance; Glucose Transporter Type 4; Hyperglycemia; Male; Monosaccharide Transport Proteins; Muscle Proteins; Rats; Rats, Wistar; Semicarbazides; Vanadates | 2001 |
Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
Topics: Adipocytes; Adipose Tissue; Amine Oxidase (Copper-Containing); Animals; Benzylamines; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glucose; Kidney; Lipolysis; Liver; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Myocardium; Oxidation-Reduction; Pargyline; Rats; Rats, Wistar; Semicarbazides; Tyramine; Vanadates | 2005 |